Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rebecca Rothenheber"'
Autor:
Meggy Suarez-Carmona, Pornpimol Chaorentong, Jakob Nikolas Kather, Rebecca Rothenheber, Azaz Ahmed, Anna Berthel, Anita Heinzelmann, Rodrigo Moraleda, Nektarios A. Valous, Zeynep Kosaloglu, Rosa Eurich, Jana Wolf, Silke Grauling-Halama, Michael Hundemer, Felix Lasitschka, Fee Klupp, Christoph Kahlert, Alexis Ulrich, Martin Schneider, Christine Falk, Dirk Jäger, Inka Zoernig, Niels Halama
Publikováno v:
OncoImmunology, Vol 8, Iss 9 (2019)
Multiple reports have highlighted the importance of the local immunological cellular composition (i.e. the density of effector T cells and macrophage polarization state) in predicting clinical outcome in advanced metastatic stage of colorectal cancer
Externí odkaz:
https://doaj.org/article/844c14f93b264ecc9dca36e19969b94b
Autor:
Silke A Grauling-Halama, Rosa Eurich, Meggy Suarez-Carmona, Christine S. Falk, Niels Halama, Anna Berthel, Jakob Nikolas Kather, Felix Lasitschka, Alexis Ulrich, Martin Schneider, Michael Hundemer, Azaz Ahmed, Anita Heinzelmann, Christoph Kahlert, Pornpimol Chaorentong, Fee Klupp, Jana Wolf, Nektarios A. Valous, Zeynep Kosaloglu, Inka Zoernig, Dirk Jäger, Rebecca Rothenheber, Rodrigo Rojas Moraleda
Publikováno v:
OncoImmunology 8(9), e1626193 (2019). doi:10.1080/2162402X.2019.1626193
Oncoimmunology
OncoImmunology, Vol 8, Iss 9 (2019)
Oncoimmunology
OncoImmunology, Vol 8, Iss 9 (2019)
OncoImmunology 8(9), e1626193 (2019). doi:10.1080/2162402X.2019.1626193
Published by Taylor & Franics, Abingdon
Published by Taylor & Franics, Abingdon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46978ce5a86c461b6148db4db290aaba
Autor:
Frank Momburg, Marten Meyer, Niels Halama, Meggy Suarez-Carmona, Sarah Schott, B. Lenoir, Inka Zoernig, Rebecca Rothenheber, Dyke Ferber, Dirk Jäger
Publikováno v:
Cancer Immunology Research. 7:A069-A069
Despite the immense research over the past decade in the cancer immunology field, which has led to several clinical trials and FDA and EMA approvals of biologicals for the reinvigoration of T-cell-mediated cancer cell killing in diverse tumor entitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1f5eb7c46a3fae1652db95cd56a062a
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a069
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a069